/PRNewswire/ XNK Therapeutics AB ("XNK") today said the company would continue its partnership with the Karolinska Cell Therapy Center s production unit.
XNK Therapeutics continues platform development work with AdBIOPRO after Sweden's Vinnova extends investment - read this article along with other careers information, tips and advice on BioSpace